About Spandan Khandelwal
Spandan's is a financial journalist and investment analyst focused on the stock market. With her ability to interpret financial data, she aims to help investors evaluate the fundamentals of a company before investing.
Spandan majored in accounting and finance in college and is currently pursuing the Cost and Management Accountant (CMA) program.
Recent Articles By Spandan Khandelwal
This 1 Energy Stock Has Major Momentum — Is It a Buy?
Birchcliff Energy Ltd. (BIREF), an intermediate oil and natural gas company, reported strong quarterly results, with robust fund flows and impressive production. The stock has garnered significant investor attention and soared nearly 100% over the past year. Is it worth adding the stock to your portfolio now? Let’s find out…
3 Under the Radar Penny Stocks to Buy Now
The Fed’s aggressive interest rate hikes and the economy's contraction for two consecutive quarters have increased the odds of a potential recession. Nevertheless, robust corporate earnings and some positive economic data have greatly supported the downside of the benchmark indexes lately. Therefore, we think it could be wise to invest in under-the-radar penny stocks ARC Document (ARC), Dynagas LNG (DLNG), and TransGlobe Energy (TGA) with solid upside potential. Read on...
Is Costco Stock Still a Buy Amid Retail Troubles?
Retail companies have faced significant headwinds this year due to sky-high inflation and supply chain disruptions. However, Costco Wholesale's (COST) strong revenue performance and consistent margins have helped the stock to remain resilient amid retail troubles. So is this stock worth adding to your portfolio now? Let’s find out…
3 Health Care ETFs You'll Want to Own When the Market Recovers
Last month, the S&P 500 witnessed its best month in two years after suffering its worst-first half since 1970. However, the multi-decade high inflation and the GDP decline for two consecutive quarters could continue to impact investor sentiment. Therefore, one could invest in healthcare ETFs, ETFs First Trust Nasdaq Pharmaceuticals (FTXH), Vanguard Health Care (VHT) VanEck Vectors (PPH) once the market recovers to benefit from the industry's solid growth prospects. Read on…
Nancy Pelosi Sells Shares of Visa — Should You?
Despite heightened recession fears, shares of Visa (V) remained relatively unaffected given the company’s robust payment volume and cross-border volume in the fiscal third quarter. However, House Speaker Nancy Pelosi and her husband sold millions of dollars of V shares in June. So, is the stock worth adding to your portfolio now? Let’s find out...
3 Cheap Stocks You Don't Want to Overlook
While July turned out to be the best month for the stock market since 2020, the volatility is unlikely to abate anytime soon due to recession worries. So, it may be prudent to invest in quality stocks AstroNova (ALOT), Overseas Shipholding Group (OSG), and Rimini Street (RMNI), which are trading at a discount to their peers. Read on…
2 ETFs to Focus on Following Big Tech Earnings
Amid increasing concerns over multi-decade high inflation and aggressive interest rate hikes, better-than-expected earnings of many tech giants have aided the stock market rally. Therefore, we think it could be wise to invest in tech-focused ETFs ProShares S&P Technology Dividend Aristocrats ETF (TDV) and Innovator Nasdaq-100 Power Buffer ETF – October (NOCT). Read on to learn more…
3 Dividend-Paying Stocks to Consider During a Recession
Rising inflation, the Fed’s hawkish stance to tame it, and an economic contraction for two consecutive quarters have stoked fears of a recession in the U.S. economy. Amid the likely economic downturn, investors could consider investing in stocks that provide a steady income in the form of dividends. Therefore, we think quality dividend stocks AbbVie (ABBV), Eli Lilly and Company (LLY), and Johnson & Johnson (JNJ) are great recession picks. Read on…
The Smartest Tobacco Stock to Buy for the Long Haul
Altria Group (MO) reported weak second-quarter revenues but reaffirmed its EPS guidance range for 2022. While the stock may remain under pressure in the near term due to the broader market volatility, the company’s strong profitability and reasonable valuation make it a solid long-term investment. Read on…